SCHEMBL7017546

SCHEMBL7017546

CCOC(=O)c1cnc(SCC)nc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.54
SMN1; SMN2 Q16637 8/20 0.54
RAB9A P51151 6/20 0.54
NPC1 O15118 6/20 0.54
NFKB1 P19838 2/20 0.54
NFKB2 Q00653 2/20 0.54
RELA Q04206 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
KDM4E B2RXH2 1/20 0.53
MAPT P10636 7/20 0.53
TSHR P16473 2/20 0.51
MAPK1 P28482 1/20 0.51
HSD17B10 Q99714 1/20 0.51
RECQL P46063 1/20 0.51
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188686 0.87 MAPT (0.61) ALDH1A1SMN1; SMN2RAB9ANPC1NFKB1
SCHEMBL29506595 0.87 MAPT (0.61) ALDH1A1SMN1; SMN2RAB9ANPC1NFKB1
SCHEMBL11014853 0.87 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2RAB9ANPC1NFKB1
SCHEMBL28520505 0.85 SMN1; SMN2 (0.68) ALDH1A1SMN1; SMN2RAB9ANPC1NFKB1
SCHEMBL2908655 0.85 RAB9A (0.56) ALDH1A1SMN1; SMN2RAB9ANPC1NFKB1
SCHEMBL7024255 0.84 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2RAB9ANPC1NFKB1
SCHEMBL1991090 0.83 SMN1; SMN2 (0.76) ALDH1A1SMN1; SMN2RAB9ANPC1NFKB1
SCHEMBL16152794 0.82 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2RAB9ANPC1NFKB1
SCHEMBL10559871 0.82 ALDH1A1 (0.45) ALDH1A1SMN1; SMN2RAB9ANPC1NFKB1
SCHEMBL5808541 0.81 MEN1 (0.58) ALDH1A1SMN1; SMN2RAB9ANPC1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed
US-4556709-A BACTERICIDES, FEED ADDITIVES BAYER AKTIENGESELLSCHAFT (DE) 1985-12-03 US disclosed
EP-0142040-A2 Substituted pyrimidines BAYER AG (DE) 1985-05-22 EP disclosed